Zynex EV/EBIT
Qual é o EV/EBIT de Zynex?
O EV/EBIT de Zynex, Inc. é 21.27
Qual é a definição de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de empresas na Setor Health Care em EURONEXT em comparação com Zynex
O que Zynex faz?
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Empresas com ev/ebit semelhantes a Zynex
- Intercontinental Exch.Inc tem EV/EBIT de 21.23
- Ørsted A/S tem EV/EBIT de 21.23
- SGS SA tem EV/EBIT de 21.25
- Sacheta Metals tem EV/EBIT de 21.25
- Xcel tem EV/EBIT de 21.26
- Wirecard AG tem EV/EBIT de 21.27
- Zynex tem EV/EBIT de 21.27
- Saia tem EV/EBIT de 21.27
- Bausch Health Companies Inc tem EV/EBIT de 21.28
- Punjab Chemicals and Crop Protection tem EV/EBIT de 21.28
- Casey`s General Stores tem EV/EBIT de 21.28
- The Sukhjit Starch & Chemicals tem EV/EBIT de 21.28
- India Nippon Electricals tem EV/EBIT de 21.28